Raisman R, Sette M, Pimoule C, Briley M, Langer S Z
Eur J Pharmacol. 1982 Mar 12;78(3):345-51. doi: 10.1016/0014-2999(82)90036-x.
The specific binding of [3H]desipramine to various brain regions and peripheral tissues of the rat was of high affinity, rapid and reversible. It was inhibited with high affinity only by tricyclic antidepressants and noradrenaline uptake blockers. There was a highly significant correlation between the potencies of a series of drugs for the inhibition of [3H]desipramine binding and for the inhibition of noradrenaline uptake. Substrates for the noradrenaline uptake system however inhibited the binding of [3H]desipramine only at very high concentrations. Postganglionic sympathetic denervation of the submaxillary gland and the heart both resulted in a pronounced decrease in [3H]desipramine binding sites, which paralleled the reduction in endogenous noradrenaline levels. High-affinity [3H]desipramine binding sites thus appear to be localised on noradrenergic nerve endings and are probably closely associated with the neuronal uptake system for noradrenaline.
[3H]去甲丙咪嗪与大鼠不同脑区及外周组织的特异性结合具有高亲和力、快速且可逆。仅三环类抗抑郁药和去甲肾上腺素摄取阻滞剂能以高亲和力抑制其结合。一系列药物抑制[3H]去甲丙咪嗪结合的效力与其抑制去甲肾上腺素摄取的效力之间存在高度显著的相关性。然而,去甲肾上腺素摄取系统的底物仅在非常高的浓度下才会抑制[3H]去甲丙咪嗪的结合。下颌下腺和心脏的节后交感神经去神经支配均导致[3H]去甲丙咪嗪结合位点显著减少,这与内源性去甲肾上腺素水平的降低相平行。因此,高亲和力的[3H]去甲丙咪嗪结合位点似乎定位于去甲肾上腺素能神经末梢,并且可能与去甲肾上腺素的神经元摄取系统密切相关。